Evidence map›Paper›PMID 39399308›Full record

ArticleResearch and reports in urology2024

Incidence and Recurrence of Urinary Tract Infections Caused by Uropathogenic

Eva Raphael, Lorenzo Argante, Elisa Cinconze, Sara Nannizzi, Cheyenne Belmont, Claire F Mastrangelo, Yuan Hu Allegretti, Michele Pellegrini, Johannes E Schmidt

Abstract read
In one paragraph

Article in Research and reports in urology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Article
  2. Review
  3. Urological Manifestation of Mpox Virus: A Scoping Review.Research and reports in urology · 2025
    Review
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Eva RaphaelDepartment of Epidemiology and Biostatistics, University of California, San Francisco, CA, USA.ORCID 0000-0003-2854-0247
Lorenzo ArganteClinical Research and Development Center, GSK, Siena, Italy.ORCID 0000-0001-6853-068X
Elisa CinconzeClinical Research and Development Center, GSK, Siena, Italy.ORCID 0000-0001-9174-6438
Sara NannizziClinical Research and Development Center, GSK, Siena, Italy.
Cheyenne BelmontDepartment of Epidemiology and Biostatistics, University of California, San Francisco, CA, USA.
Claire F MastrangeloDivision of Infectious Diseases and Vaccinology, School of Public Health - University of California, Berkeley, CA, USA.
Yuan Hu AllegrettiDivision of Epidemiology, School of Public Health - University of California, Berkeley, CA, USA.
Michele PellegriniClinical Research and Development Center, GSK, Siena, Italy.ORCID 0000-0002-9111-5828
Johannes E SchmidtClinical Research and Development Center, GSK, Siena, Italy.

Funding

UCSF-Kaiser Urological Epidemiology Research Career Development ProgramK12DK111028 · NIDDK · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI HUANG, ALISON · 2016 to 2025
$5.3M
Community-onset urinary tract infections caused by extended-spectrum beta-lactamase-producing Escherichia coli in women of diverse backgroundsK23AI166030 · NIAID · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI Eva Raphael · 2022 to 2026
$1.1M
NIAID NIH HHS K23 AI166030NIAID NIH HHS L30 AI154576NIDDK NIH HHS K12 DK111028
6 · The paper itself

Abstract

Purpose: Urinary tract infections (UTIs) are among the most common bacterial infections, with uropathogenic Patients and Methods: This retrospective cohort study aimed to assess the incidence of uUTIs caused by UPEC (UPEC-uUTIs) or unknown etiology (untested uUTIs) in adults aged ≥18 years receiving care in a San Francisco healthcare system. Results: During 2014-2019, 1087 UPEC-uUTI and 4106 untested uUTI cases were documented, of which 324 (29.8%; 95% confidence interval: 27.1%-32.6%) and 1030 (25.1%; 95% confidence interval: 23.8%-26.4%) were followed by ≥1 new episode of uUTI within 12 months. In the UPEC-uUTI cohort, male gender, diagnosis of diabetes mellitus, and prior uUTI were risk factors for new episodes of uUTI. At the time of first UPEC-uUTI diagnosis, antimicrobial prescriptions were retrieved for 41.1% of cases. When tested, AMR was most frequently reported for trimethoprim/sulfamethoxazole or trimethoprim/sulfamethoxazole prescribed with other antimicrobials. Conclusion: Our study provides important information on the incidence and risk of repeated episodes of uUTIs, as well as on AMR related to them.

Indexed as

antimicrobial resistanceuncomplicated urinary tract infectionurinary tract infection preventionurinary tract infection risk factors

Identifiers

PMID39399308
PMCPMC11471108

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.